Original languageEnglish (US)
Title of host publicationHandbook of Clinical Nanomedicine
Subtitle of host publicationLaw, Business, Regulation, Safety, and Risk
PublisherPan Stanford Publishing Pte. Ltd.
Pages1253-1268
Number of pages16
Volume2
ISBN (Electronic)9789814669238
ISBN (Print)9789814669221
DOIs
StatePublished - May 2 2016

Keywords

  • Alzheimer's disease (ad)
  • American society for nanomedicine (asnm)
  • Amyotrophic lateral sclerosis (als)
  • Bioimaging
  • Blood-brain barrier (bbb)
  • Drug targeting
  • Hiv
  • Hypothermia
  • Magnetic nanoparticles
  • Mri
  • Multiple sclerosis (ms)
  • Nanoneuromedicine
  • Nanotoxicity
  • Neurodegenerative disorders
  • Parkinson's disease (pd)
  • Pet
  • Small magnetite antiretroviral therapy (smart)
  • Superparamagnetic iron oxide (spio)
  • Theranostics
  • Therapeutic monitoring

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Engineering(all)
  • Materials Science(all)

Cite this

Gendelman, H. E., Mosley, R. L., Boska, M. D., & McMillan, J. E. (2016). The promise of nanoneuromedicine: An editorial. In Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk (Vol. 2, pp. 1253-1268). Pan Stanford Publishing Pte. Ltd.. https://doi.org/10.4032/9789814669238